Page 93 - e-CPG-SLE-8_5_24

Management of Systemic Lupus Erythematosus

LIST OF ABBREVIATIONS

24hUP 24-hour urine protein
aCL anticardiolipin antibodies
ACR American College of Rheumatology
AE adverse event
AGREE Appraisal of Guidelines for Research and Evaluation
AIHA autoimmune haemolytic anaemia
ALMS Aspreva Lupus Management Study
ALP alkaline phosphatase
ANA antinuclear antibodies
anti-β2GP1 anti-beta-2-glycoprotein 1
anti-dsDNA anti-double stranded deoxyribonucleic acid
anti-RNP antibodies to ribonucleoprotein
anti-Sm anti-Smith
anti-SSA anti-Sjögren’s-syndrome-related antigen A
anti-SSB anti-Sjögren’s-syndrome-related antigen B
aPL antiphospholipid antibodies
APS antiphospholipid syndrome
ARA American Rheumatism Association
AZA azathioprine
BAFF B-cell activating factor
BD bis in die (twice a daily)
BICLA British Isles Lupus Assessment Group-based Composite Lupus
Assessment
BILAG British Isles Lupus Activity Group
BLISS Belimumab in Subjects with Systemic Lupus Erythematosus
BLyS B-lymphocyte stimulator
BMD bone mineral density
BMI body-mass index
BSR British Society for Rheumatology
C3 complement 3
C4 complement 4
CI confidence interval
CLASI Cutaneous Lupus Erythematosus Disease Area and Severity Index
CLE cutaneous lupus erythematosus
CNI calcineurin inhibitors
COX-2 cyclooxygenase-2
CPG clinical practice guidelines
CrCl creatinine clearance
CRP C-reactive protein
CT computed tomography
CYC cyclophosphamide
CV cardiovascular
CVD cardiovascular disease
DG development group
DMPA depot medroxyprogesterone acetate
DOAC direct oral anticoagulant
DORIS Definition of Remission in SLE
DNA deoxyribonucleic acid
ECG electrocardiogram
eGFR estimated glomerular filtration rate

76